A detailed history of Morgan Stanley transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Morgan Stanley holds 1,102,852 shares of ENTA stock, worth $10.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,102,852
Previous 1,456,559 24.28%
Holding current value
$10.3 Million
Previous $18.9 Million 39.46%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.05 - $16.54 $3.55 Million - $5.85 Million
-353,707 Reduced 24.28%
1,102,852 $11.4 Million
Q2 2024

Oct 17, 2024

SELL
$11.43 - $17.02 $6.73 Million - $10 Million
-588,586 Reduced 28.78%
1,456,559 $18.9 Million
Q2 2024

Aug 14, 2024

SELL
$11.43 - $17.02 $6.73 Million - $10 Million
-588,586 Reduced 28.78%
1,456,559 $18.9 Million
Q1 2024

Oct 17, 2024

BUY
$10.08 - $17.46 $5.93 Million - $10.3 Million
588,586 Added 40.41%
2,045,145 $35.7 Million
Q1 2024

Aug 16, 2024

BUY
$10.08 - $17.46 $8.79 Million - $15.2 Million
872,087 Added 74.34%
2,045,145 $35.7 Million
Q1 2024

May 15, 2024

BUY
$10.08 - $17.46 $8.79 Million - $15.2 Million
872,087 Added 74.34%
2,045,145 $35.7 Million
Q4 2023

Aug 16, 2024

SELL
$8.18 - $10.78 $2.32 Million - $3.06 Million
-283,501 Reduced 19.46%
1,173,058 $11 Million
Q4 2023

Feb 13, 2024

BUY
$8.18 - $10.78 $4.98 Million - $6.56 Million
608,492 Added 107.78%
1,173,058 $11 Million
Q3 2023

Nov 15, 2023

BUY
$11.09 - $22.13 $2.85 Million - $5.69 Million
257,264 Added 83.72%
564,566 $6.31 Million
Q2 2023

Aug 14, 2023

BUY
$20.68 - $39.85 $3.63 Million - $6.99 Million
175,354 Added 132.9%
307,302 $6.58 Million
Q1 2023

May 15, 2023

SELL
$38.82 - $54.59 $255,319 - $359,038
-6,577 Reduced 4.75%
131,948 $5.34 Million
Q4 2022

Feb 14, 2023

SELL
$40.77 - $53.73 $1.76 Million - $2.32 Million
-43,149 Reduced 23.75%
138,525 $6.44 Million
Q3 2022

Nov 14, 2022

SELL
$48.29 - $71.27 $3.05 Million - $4.5 Million
-63,200 Reduced 25.81%
181,674 $9.42 Million
Q2 2022

Oct 27, 2022

BUY
$38.13 - $76.93 $2.99 Million - $6.03 Million
78,326 Added 47.03%
244,874 $11.6 Million
Q2 2022

Aug 15, 2022

BUY
$38.13 - $76.93 $2.99 Million - $6.03 Million
78,326 Added 47.03%
244,874 $11.6 Million
Q1 2022

Oct 27, 2022

SELL
$56.06 - $74.11 $4.39 Million - $5.8 Million
-78,326 Reduced 31.99%
166,548 $11.9 Million
Q1 2022

May 13, 2022

BUY
$56.06 - $74.11 $2.27 Million - $3 Million
40,479 Added 32.11%
166,548 $11.9 Million
Q4 2021

Feb 14, 2022

SELL
$60.19 - $97.37 $2.18 Million - $3.52 Million
-36,163 Reduced 22.29%
126,069 $9.43 Million
Q3 2021

Nov 15, 2021

BUY
$41.02 - $58.65 $6.65 Million - $9.51 Million
162,232 New
162,232 $9.22 Million

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $194M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.